Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Spengler

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 7, 2015
Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysisTatiana Hildebrand, Nadine Pannicke, Alexander Dechene, et al.
The Lancet. Infectious Diseases|December 29, 2016
Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 studyKatja Deterding, Christoph D Spinner, Eckart Schott, et al.
Plos One|June 5, 2013
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentChristian M Lange, Daiki Miki, Hidenori Ochi, et al.
Gastroenterology|November 18, 2017
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting AntiviralsJulia Dietz, Simone Susser, Johannes Vermehren, et al.
Gut|May 20, 2016
Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infectionJanett Fischer, Alexander N R Weber, Stephan Böhm, et al.
Immunity|January 6, 2022
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralizationTimm Weber, Julian Potthoff, Sven Bizu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 10, 2019
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 InfectionsJulia Dietz, Ulrich Spengler, Beat Müllhaupt, et al.
The Journal of Infectious Diseases|March 21, 2022
Mitochondrial Dysfunction Contributes to Impaired Cytokine Production of CD56bright Natural Killer Cells From Human Immunodeficiency Virus-Infected Individuals Under Effective Antiretroviral TherapyMichael ToVinh, Gregor Hörr, Kristiyana Dobrikova, et al.
The American Journal of Gastroenterology|June 14, 2018
Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related CirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
The American Journal of Gastroenterology|March 15, 2018
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 7, 2015
Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysisTatiana Hildebrand, Nadine Pannicke, Alexander Dechene, et al.
The Lancet. Infectious Diseases|December 29, 2016
Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 studyKatja Deterding, Christoph D Spinner, Eckart Schott, et al.
Plos One|June 5, 2013
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentChristian M Lange, Daiki Miki, Hidenori Ochi, et al.
Gastroenterology|November 18, 2017
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting AntiviralsJulia Dietz, Simone Susser, Johannes Vermehren, et al.
Gut|May 20, 2016
Sex-specific effects of TLR9 promoter variants on spontaneous clearance of HCV infectionJanett Fischer, Alexander N R Weber, Stephan Böhm, et al.
Immunity|January 6, 2022
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralizationTimm Weber, Julian Potthoff, Sven Bizu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 10, 2019
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 InfectionsJulia Dietz, Ulrich Spengler, Beat Müllhaupt, et al.
The Journal of Infectious Diseases|March 21, 2022
Mitochondrial Dysfunction Contributes to Impaired Cytokine Production of CD56bright Natural Killer Cells From Human Immunodeficiency Virus-Infected Individuals Under Effective Antiretroviral TherapyMichael ToVinh, Gregor Hörr, Kristiyana Dobrikova, et al.
The American Journal of Gastroenterology|June 14, 2018
Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related CirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
The American Journal of Gastroenterology|March 15, 2018
Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosisFelix Stickel, Stephan Buch, Hans Dieter Nischalke, et al.
Pageof 23